Pitfalls, pearls, and practicalities in the diagnosis of Helicobacter pylori infection
Gary Falk, MD
Department of Gastroenterology & Hepatology, Cleveland Clinic Foundation, Cleveland, OH
Leonard Ehrlich, MD
George Washington University School of Medicine, Washington, DC
A. Mark Fendrick, MD
Division of General Medicine, University of Michigan Health System, Ann Arbor, Ml
M. Brian Fennerty, MD
Division of Gastroenterology, Oregon Health & Science University, Portland, OR
Ben Gold, MD
Division of Pediatric Gastroenterology and Nutrition, Emory University School of Medicine, Atlanta, GA
Nimish Vakil, MD
University of Wisconsin Medical School and Marquette College of Health Sciences, Milwaukee, WI
Derek van Amerongen, MD, MS
Chief Medical Officer, Humana Health Plan of Ohio, Cincinnati, OH
David Wyatt, MD
Eagles Landing Family Practice, McDonough, GA
Gary Falk, MD, has served as a consultant to AstraZeneca Pharmaceuticals and Meridian Bioscience.
Brian Fennerty, MD, has served as a consultant to AstraZeneca Pharmaceuticals, Eisai, Meridian Bioscience, Santarus, and TAP Pharmaceutical Products.
Ben Gold, MD, has served as a consultant to AstraZeneca Pharmaceuticals, Meridian Bioscience, Meretek Diagnostics, and TAP Pharmaceutical Products.
Nimish Vakil, MD, has received grant/research support from AstraZeneca Pharmaceuticals, Medtronic, Novartis, and Pfizer; has served as a consultant to AstraZeneca, Medtronic, Meridian Bioscience, and Novartis; and is on the speakers’ bureaus of AstraZeneca, Novartis, and TAP Pharmaceutical Products.
Leonard Ehrlich, MD, A. Mark Fendrick, MD, Derek van Amerongen, MD, and David Wyatt, MD, have served as consultants to Meridian Bioscience.
- Nimish Vakil, MD
- A. Mark Fendrick, MD